Please login to the form below
Clinolipid
This page shows the latest Clinolipid news and features for those working in and with pharma, biotech and healthcare.
Swift US approval for Baxter’s nutritional supplement
FDA backs Clinolipid to alleviate shortage of drugs for people unable to eat or drink. . ... The US Food and Drug Administration (FDA) has approved Baxter's Clinolipid as an intravenous nutritional supplements for adult patients unable to eat or drink.
Latest news
-
US shutdown "hurting business"
shutdown. For example, Baxter has secured approval for its Clinolipid intravenous nutritional supplement on Friday, while Discovery Labs has been given a green light for updated specifications for its Surfaxin (lucinactant)
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Consultant
-
competitive salary
Subscribe to our email news alerts
- Moving annual total (MAT)
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- Immuno-oncology, personalised medicine continues to drive pharma sector
- FDA delays decision on Intercept's NASH drug by three months
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- New coronavirus sees drug developers scramble to develop a vaccine
- Sanofi completes acquisition of immuno-oncology specialist Synthorx
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Epizyme wins FDA approval for epithelioid sarcoma treatment
- Pharma Brand Planners' Blog (Part 8)
- Happy Chinese New Year 2020 - The Year of The Rat
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- Happy Chinese New Year 2020 - The Year of The Rat
- A fond farewell to The Year of the Pig...
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Quick links
Infographics
